ArticleHaematologica2025
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
Binu Kandathilparambil Sasi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it